<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19692580</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1754-8411</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>9-10</Issue><PubDate><Year>2009</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Disease models &amp; mechanisms</Title><ISOAbbreviation>Dis Model Mech</ISOAbbreviation></Journal><ArticleTitle>Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice.</ArticleTitle><Pagination><StartPage>500</StartPage><EndPage>507</EndPage><MedlinePgn>500-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1242/dmm.003301</ELocationID><Abstract><AbstractText>Here, we used a mouse model of Kennedy disease, a degenerative disorder caused by an expanded CAG repeat in the androgen receptor (AR) gene, to explore pathways leading to cellular dysfunction. We demonstrate that male mice containing a targeted Ar allele with 113 CAG repeats (AR113Q mice) exhibit hormone- and glutamine length-dependent missplicing of Clcn1 RNA in skeletal muscle. Changes in RNA splicing are associated with increased expression of the RNA-binding protein CUGBP1. Furthermore, we show that skeletal muscle denervation in the absence of a repeat expansion leads to increased CUGBP1 expression. However, this induction of CUGBP1 is not sufficient to alter Clcn1 RNA splicing, indicating that changes mediated by both denervation and AR113Q toxicity contribute to altered RNA processing. To test this notion directly, we exogenously expressed the AR in vitro and observed hormone-dependent changes in the splicing of pre-mRNAs from a human cardiac troponin T minigene. These effects were notably similar to changes mediated by RNA with expanded CUG tracts, but not CAG tracts, highlighting unanticipated similarities between CAG and CUG repeat diseases. The expanded glutamine AR also altered hormone-dependent splicing of a calcitonin/calcitonin gene-related peptide minigene, suggesting that toxicity of the mutant protein additionally affects RNA processing pathways that are distinct from those regulated by CUGBP1. Our studies demonstrate the occurrence of hormone-dependent alterations in RNA splicing in Kennedy disease models, and they indicate that these changes are mediated by both the cell-autonomous effects of the expanded glutamine AR protein and by alterations in skeletal muscle that are secondary to denervation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pathology, The University of Michigan Medical School, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Adrienne M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>Diane M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS055746</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS055746-04</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 NS076401</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dis Model Mech</MedlineTA><NlmUniqueID>101483332</NlmUniqueID><ISSNLinking>1754-8403</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067879">CELF1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C502743">CELF1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086321">CLC-1 channel</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018118">Chloride Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020107">Troponin T</NameOfSubstance></Chemical><Chemical><RegistryNumber>0RH81L854J</RegistryNumber><NameOfSubstance UI="D005973">Glutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067879" MajorTopicYN="N">CELF1 Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018118" MajorTopicYN="N">Chloride Channels</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005091" MajorTopicYN="N">Exons</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055879" MajorTopicYN="Y">Gene Knock-In Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005973" MajorTopicYN="N">Glutamine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008817" MajorTopicYN="N">Mice, Mutant Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009121" MajorTopicYN="N">Muscle Denervation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012326" MajorTopicYN="N">RNA Splicing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020107" MajorTopicYN="N">Troponin T</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>8</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>8</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19692580</ArticleId><ArticleId IdType="pmc">PMC2737058</ArticleId><ArticleId IdType="doi">10.1242/dmm.003301</ArticleId><ArticleId IdType="pii">dmm.003301</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abel A, Walcott J, Woods J, Duda J, Merry DE. (2001). Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum Mol Genet. 10, 107&#x2013;116</Citation><ArticleIdList><ArticleId IdType="pubmed">11152658</ArticleId></ArticleIdList></Reference><Reference><Citation>Albertelli MA, Scheller A, Brogley M, Robins DM. (2006). Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol. 20, 1248&#x2013;1260</Citation><ArticleIdList><ArticleId IdType="pubmed">16601069</ArticleId></ArticleIdList></Reference><Reference><Citation>Auboeuf D, Honig A, Berget SM, O&#x2019;Malley BW. (2002). Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298, 416&#x2013;419</Citation><ArticleIdList><ArticleId IdType="pubmed">12376702</ArticleId></ArticleIdList></Reference><Reference><Citation>Auboeuf D, Dowhan DH, Kang YK, Larkin K, Lee JW, Berget SM, O&#x2019;Malley BW. (2004). Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc Natl Acad Sci USA 101, 2270&#x2013;2274</Citation><ArticleIdList><ArticleId IdType="pmc">PMC356940</ArticleId><ArticleId IdType="pubmed">14982999</ArticleId></ArticleIdList></Reference><Reference><Citation>Auboeuf D, Batsche E, Dutertre M, Muchardt C, O&#x2019;Malley BW. (2007). Coregulators: transducing signal from transcription to alternative splicing. Trends Endocrinol Metab. 18, 122&#x2013;129</Citation><ArticleIdList><ArticleId IdType="pubmed">17320409</ArticleId></ArticleIdList></Reference><Reference><Citation>Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, et al. (1992). Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3&#x2032; end of a transcript encoding a protein kinase family member. Cell 69, 385.</Citation><ArticleIdList><ArticleId IdType="pubmed">1568252</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamberlain NL, Driver ED, Miesfeld RL. (1994). The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22, 3181&#x2013;3186</Citation><ArticleIdList><ArticleId IdType="pmc">PMC310294</ArticleId><ArticleId IdType="pubmed">8065934</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlet BN, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. (2002). Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10, 45&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">12150906</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen ES, O&#x2019;Brien CJ, Wang H, Jenkins SC, Holder L, Lieberman AP, Merry DE. (2004). Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci. 24, 4778&#x2013;4786</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho DH, Thienes CP, Mahoney SE, Analau E, Filippova GN, Tapscott SJ. (2005). Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell 20, 483&#x2013;489</Citation><ArticleIdList><ArticleId IdType="pubmed">16285929</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Sweet J, Challis JR, Brown T, Lye SJ. (2007). Transcriptional activity of androgen receptor is modulated by two RNA splicing factors, PSF and p54nrb. Mol Cell Biol. 27, 4863&#x2013;4875</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951499</ArticleId><ArticleId IdType="pubmed">17452459</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S, Goto K, Chen G, Morinaga H, Nomura M, Okabe T, Nawata H, Yanase T. (2006). Identification of the functional domains of ANT-1, a novel coactivator of the androgen receptor. Biochem Biophys Res Commun. 341, 192&#x2013;201</Citation><ArticleIdList><ArticleId IdType="pubmed">16414017</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu YH, Pizzuti A, Fenwick RG, Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, et al. (1992). An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256&#x2013;1258</Citation><ArticleIdList><ArticleId IdType="pubmed">1546326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho TH, Bundman D, Armstrong DL, Cooper TA. (2005a). Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet. 14, 1539&#x2013;1547</Citation><ArticleIdList><ArticleId IdType="pubmed">15843400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA. (2005b). Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J Cell Sci. 118, 2923&#x2013;2933</Citation><ArticleIdList><ArticleId IdType="pubmed">15961406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. (2003). A muscleblind knockout model for myotonic dystrophy. Science 302, 1978&#x2013;1980</Citation><ArticleIdList><ArticleId IdType="pubmed">14671308</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Waza M, Banno H, Suzuki K, Tanaka F, Doyu M, Sobue G. (2006). Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA). Exp Neurol. 200, 8&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pubmed">16513111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemi-Esfarjani P, Trifiro MA, Pinsky L. (1995). Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet. 4, 523&#x2013;527</Citation><ArticleIdList><ArticleId IdType="pubmed">7633399</ArticleId></ArticleIdList></Reference><Reference><Citation>Klocke R, Steinmeyer K, Jentsch TJ, Jockusch H. (1994). Role of innervation, excitability, and myogenic factors in the expression of the muscular chloride channel ClC-1: a study on normal and myotonic muscle. J Biol Chem. 269, 27635&#x2013;27639</Citation><ArticleIdList><ArticleId IdType="pubmed">7961681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrominova TY, Dow DE, Dennis RG, Miller RA, Faulkner JA. (2005). Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles. Physiol Genomics 22, 227&#x2013;243</Citation><ArticleIdList><ArticleId IdType="pubmed">15840640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu-Martinez NM, Wang GS, Cooper TA. (2007). Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 28, 68&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2083558</ArticleId><ArticleId IdType="pubmed">17936705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd PD, Smith LE, Rabaia NA, Moore JM, Georges SA, Hansen RS, Hagerman RJ, Tassone F, Tapscott SJ, Filippova GN. (2007). An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet. 16, 3174&#x2013;3187</Citation><ArticleIdList><ArticleId IdType="pubmed">17921506</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LB, Yu Z, Teng X, Bonini NM. (2008). RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453, 1107&#x2013;1111</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2574630</ArticleId><ArticleId IdType="pubmed">18449188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Fischbeck KH. (2000). Triplet repeat expansion in neuromuscular disease. Muscle Nerve 23, 843&#x2013;850</Citation><ArticleIdList><ArticleId IdType="pubmed">10842259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH. (2002). Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet. 11, 1967&#x2013;1976</Citation><ArticleIdList><ArticleId IdType="pubmed">12165558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, Thornton CA. (2006). Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet. 15, 2087&#x2013;2097</Citation><ArticleIdList><ArticleId IdType="pubmed">16717059</ArticleId></ArticleIdList></Reference><Reference><Citation>Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. (2001). Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293, 864&#x2013;867</Citation><ArticleIdList><ArticleId IdType="pubmed">11486088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA. (2000). Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769&#x2013;1773</Citation><ArticleIdList><ArticleId IdType="pubmed">10976074</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA. (2002). Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10, 35&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pubmed">12150905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejat A, Ramond F, Bassel-Duby R, Khochbin S, Olson EN, Schaeffer L. (2005). Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression. Nat Neurosci. 8, 313&#x2013;321</Citation><ArticleIdList><ArticleId IdType="pubmed">15711539</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, Pinsky L. (1993). Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet. 5, 184&#x2013;188</Citation><ArticleIdList><ArticleId IdType="pubmed">8252045</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS. (2000). Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439&#x2013;4448</Citation><ArticleIdList><ArticleId IdType="pmc">PMC302046</ArticleId><ArticleId IdType="pubmed">10970838</ArticleId></ArticleIdList></Reference><Reference><Citation>Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, Chen G, Weatherspoon MR, Clark HB, Ebner TJ, et al. (2006). Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet. 38, 758&#x2013;769</Citation><ArticleIdList><ArticleId IdType="pubmed">16804541</ArticleId></ArticleIdList></Reference><Reference><Citation>Orphanides G, Reinberg D. (2002). A unified theory of gene expression. Cell 108, 439&#x2013;451</Citation><ArticleIdList><ArticleId IdType="pubmed">11909516</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne RJ, Thornton CA. (2006). RNA-dominant diseases. Hum. Mol. Genet. 15 Spec No 2, R162&#x2013;R169</Citation><ArticleIdList><ArticleId IdType="pubmed">16987879</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips AV, Timchenko LT, Cooper TA. (1998). Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737&#x2013;741</Citation><ArticleIdList><ArticleId IdType="pubmed">9563950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranum LP, Day JW. (2004). Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet. 74, 793&#x2013;804</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1181975</ArticleId><ArticleId IdType="pubmed">15065017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranum LP, Cooper TA. (2006). RNA-mediated neuromuscular disorders. Annu Rev Neurosci. 29, 259&#x2013;277</Citation><ArticleIdList><ArticleId IdType="pubmed">16776586</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh G, Cooper TA. (2006). Minigene reporter for identification and analysis of cis elements and trans factors affecting pre-mRNA splicing. Biotechniques 41, 177&#x2013;181</Citation><ArticleIdList><ArticleId IdType="pubmed">16925019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperfeld AD, Karitzky J, Brummer D, Schreiber H, Haussler J, Ludolph AC, Hanemann CO. (2002). X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol. 59, 1921&#x2013;1926</Citation><ArticleIdList><ArticleId IdType="pubmed">12470181</ArticleId></ArticleIdList></Reference><Reference><Citation>Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS. (1996). Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24, 4407&#x2013;4414</Citation><ArticleIdList><ArticleId IdType="pmc">PMC146274</ArticleId><ArticleId IdType="pubmed">8948631</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang GS, Kearney DL, De Biasi M, Taffet G, Cooper TA. (2007). Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest. 117, 2802&#x2013;2811</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1964514</ArticleId><ArticleId IdType="pubmed">17823658</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, Scheller A, Albin RL, Robins DM, Lieberman AP. (2006a). Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am J Pathol. 168, 195&#x2013;204</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592669</ArticleId><ArticleId IdType="pubmed">16400023</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, Lieberman AP. (2006b). Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest. 116, 2663&#x2013;2672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghbi HY, Orr HT. (2000). Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 23, 217&#x2013;247</Citation><ArticleIdList><ArticleId IdType="pubmed">10845064</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>